A cross-sectional study on the use of statin among patients with atherosclerotic ischemic stroke in China
10.3760/cma.j.issn.0254-6450.2010.08.021
- VernacularTitle:中国动脉粥样硬化性缺血性脑卒中患者他汀类药物应用现状调查
- Author:
Li-Xin JIANG
1
;
Xi LI
;
Jing LI
;
Fang FENG
;
Yi-Ping CHEN
;
Zheng-Ming CHEN
;
Martin LANDRAY
;
Jane ARMITAGE
Author Information
1. 中国医学科学院北京协和医学院心血管病研究所阜外心血管病医院
- Keywords:
Stroke;
Statin;
Secondary prevention;
Cross-sectional study
- From:
Chinese Journal of Epidemiology
2010;31(8):925-928
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the degree and determinants of the use on statin among patients with atherosclerotic ischernic stroke in China. Methods In the context of an international multi-center clinical trial being undertaken in China, 5585 patients with atherosclerotic ischemic stroke were screened in 39 prestigious hospitals in 10 cities. The characteristics collected through electronic questionnaire were described and analyzed. Results All the screened patients had indications for statins. Among those, 60% of the patients had a history from 3 months to 2 years of suffering from stroke. However, up to 80% of the patients were not using statins when screened. Even in those with statins, about 1/4 of the patients took statins for much shorter period than the history of stroke. The proportion using statins among IS patients with CHD was 4 times more than in those without CHD. Simvastatin and Atorvastatin were most commonly used. Conclusion Statins were greatly nnderused for secondary prevention among patients with atherosclerotic ischemic stroke in China. There was a large gap between evidence and practice. It remains a major challenge for healthcare professionals and policy makers to tackle this problem more positively.
